Biotechnology Industry News: Industry Center – Yahoo Finance

Posted: October 26, 2016 at 10:42 am

Latest News Wednesday, Oct 26, 2016 Former Santa Fe Natural Tobacco Company Executive Joins 22nd Century Business Wire - 52 minutes ago Pluristem Stock Soars 8% on $30M Chinese VC (PSTI) at Investopedia - 1 hour, 14 minutes ago Rexahn Pharmaceuticals Receives U.S. Patent for RX-21101: A Novel Nano-Polymer Conjugate of Docetaxel for the Targeted Treatment of Solid Tumors GlobeNewswire - 1 hour, 42 minutes ago Flex Pharma to Report Third Quarter 2016 Results on November 2, 2016 Business Wire - 1 hour, 42 minutes ago NEMUS Bioscience Announces $500,000 Preferred Stock Financing - 1 hour, 44 minutes ago Minerva Neurosciences Announces Positive Data From Six-Month Extension of Phase IIb Trial of MIN-101 Monotherapy in Schizophrenia Thomson Reuters ONE - 2 hours, 10 minutes ago OncoMed Pharmaceuticals to Report Financial Results for the Third Quarter on Tuesday, November 1, 2016 GlobeNewswire - 2 hours, 12 minutes ago Ultragenyx Announces First Patient Enrolled in Global Phase 3 Study of KRN23 in Pediatric Patients with X-Linked Hypophosphatemia (XLH) GlobeNewswire - 2 hours, 12 minutes ago Minerva Neurosciences Announces Positive Data From Six-Month Extension of Phase IIb Trial of MIN-101 Monotherapy in Schizophrenia GlobeNewswire - 2 hours, 12 minutes ago Medgenics to Host Conference Call to Announce Third Quarter 2016 Financial Results Marketwire - 2 hours, 12 minutes ago Acasti Pharma Builds Intellectual Property Portfolio with Newly Issued U.S. Patent for CaPre Marketwire - 2 hours, 42 minutes ago Xencor to Host Third Quarter 2016 Financial Results Webcast and Conference Call on November 2, 2016 PR Newswire - 2 hours, 42 minutes ago Paratek Pharmaceuticals, Inc. to Host R&D Day on November 17, 2016 GlobeNewswire - 2 hours, 42 minutes ago Inovio Pharmaceuticals to Report Third Quarter 2016 Financial Results November 9, 2016 GlobeNewswire - 2 hours, 42 minutes ago Aeterna Zentaris Completes Patient Recruitment for Confirmatory Phase 3 Trial of Macrilen Business Wire - 2 hours, 42 minutes ago Pieris Pharmaceuticals to Receive GLP Tox Milestone Payment in Daiichi Sankyo Collaboration Marketwire - 2 hours, 42 minutes ago Lion Biotechnologies Announces Presentations at Upcoming SITC 31st Annual Meeting Marketwire - 2 hours, 42 minutes ago Ritter Pharmaceuticals, Inc. Prices $5,000,000 Public Offering of Common Stock Marketwire - 2 hours, 42 minutes ago AstraZeneca Is Now a Competitive Threat to Tesaro in Ovarian Cancer Maintenance Therapy at TheStreet.com - Wed 7:40 am ET ARIAD Announces Publication of the Preclinical Profile of Brigatinib in the Journal Clinical Cancer Research Business Wire - Wed 7:35 am ET More Latest News...

Read more from the original source:
Biotechnology Industry News: Industry Center - Yahoo Finance

Related Post